2m 2m 2m 2m 2m 2m 2m
TRAVERE THERAPET (TVTX)
NASDAQ
$65.95-$0.23 (-0.34%)
Price as of Sep 11, 2026 7:30 PM EDT- $6.2BMarket Cap
- 181.93%1-Year Change
- BiotechnologyIndustry
TRAVERE THERAPET (TVTX)
$65.95-$0.23 (-0.34%)
TVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $66.17 | ||
Change | -$1.34 (-1.98%) | ||
Open | $67.76 | ||
High | $68.73 | ||
Low | $66.11 | ||
Previous Close | $67.51 | ||
Volume | 1,149,769 | ||
30-Day Average Volume | 1,235,566 | ||
1-Week Change | 1.36% | ||
1-Month Change | 9.90% | ||
1-Year Change | 181.93% | ||
3-Year Change | 376.73% | ||
5-Year Change | 180.98% | ||
Fundamentals | |||
Shares Outstanding | 94.3M | ||
Total Assets | $799.4M | ||
Market Cap | $6.2B | ||
Enterprise Value | $6.7B | ||
Period: QTR TTM FY | |||
Revenue | $161.4M | ||
Net Income | -$34.8M | ||
Free Cash Flow | $58.1M | ||
EBIT | -$33.0M | ||
EBITDA | -$28.8M | ||
Net Working Capital | $463.1M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -234 | ||
Enterprise Value/Revenue | 42 | ||
P/B | 254 | ||
P/E | -179 | ||
PEG | -24 | ||
Price/Free Cash Flow | 107 | ||
Price/Operating Cash Flow | 107 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue